ConductScience.org, home

Paper848799

Hemodynamic improvement after oral hydralazine in left ventricular failure: a comparison with nitroprusside infusion in 16 patients.

Franciosa JA and 2 others. Ann Intern Med, 1977. Cited by 232 papers, by iCite.

Cite this record

ConductScience Library. Hemodynamic improvement after oral hydralazine in left ventricular failure: a comparison with nitroprusside infusion in 16 patients. Papers, record 848799. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/848799

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Hemodynamic improvement after oral hydralazine in left ventricular failure: a comparison with nitroprusside infusion in 16 patients.
PubMed
Journal
Ann Intern Med
PubMed
Year
1977
PubMed
Publication types
Comparative Study, Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
232
iCite
Relative citation ratio, by iCite
9.01
iCite
Revised in PubMed
2019-06-19
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Franciosa JAJ A
2Pierpont GG
3Cohn JNJ N

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
FerricyanidesMajor topic
Heart FailureMajor topic
HemodynamicsMajor topic
HydralazineMajor topic
NitroprussideMajor topic
Administration, Oral
Adult
Aged
Blood Pressure
Cardiac Output
Heart Ventricles
Humans
Infusions, Parenteral
Male
Middle Aged
Vascular Resistance

Source PubMed

Download CSV of topics

Cited by30

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 232 citations.

PMIDTitleJournalYearIn PapersSource
21874282Medical therapy for acute decompensated heart failure: what recent clinical trials have taught us about diuretics and vasodilators.Curr Heart Fail Rep2012https://conductscience.org/library/papers/21874282PubMed
18488879Carvedilol in the treatment of elderly patients with chronic heart failure.Clin Interv Aging2008https://conductscience.org/library/papers/18488879PubMed
15226814Afterload reduction in the therapy of heart failure.Tex Heart Inst J1982https://conductscience.org/library/papers/15226814PubMed
9885099Outpatient management of congestive heart failure.Tex Heart Inst J1998https://conductscience.org/library/papers/9885099PubMed
8086321Treatment of infarct related heart failure: vasodilators other than ACE inhibitors.Cardiovasc Drugs Ther1994https://conductscience.org/library/papers/8086321PubMed
7426183Haemodynamic effects of hydralazine at rest and during exercise in patients with chronic heart failure.Br Heart J1980https://conductscience.org/library/papers/7426183PubMed
7318877Clinical pharmacology of tolmesoxide in refractory heart failure.Eur J Clin Pharmacol1981https://conductscience.org/library/papers/7318877PubMed
7287364Pharmacokinetic and haemodynamic studies with prazosin in chronic heart failure.Ir J Med Sci1981https://conductscience.org/library/papers/7287364PubMed
7253539Short- and long-term effects of hydralazine and combined hydralazine-prenalterol therapy in severe chronic congestive heart failure.Klin Wochenschr1981https://conductscience.org/library/papers/7253539PubMed
7225252Vasodilator treatment with isosorbide dinitrate and hydralazine in chronic heart failure.Br Heart J1981https://conductscience.org/library/papers/7225252PubMed
6994981Clinical pharmacokinetics of prazosin.Clin Pharmacokinet1980https://conductscience.org/library/papers/6994981PubMed
6785251Afterload reduction in the therapy of heart failure.Ir J Med Sci1980https://conductscience.org/library/papers/6785251PubMed
6753903Clinical and haemodynamic responses to captopril and hydralazine in chronic congestive heart failure: the importance of preload reduction.Br J Clin Pharmacol1982https://conductscience.org/library/papers/6753903PubMed
6753895Acute and long-term effects of captopril on exercise cardiac performance and exercise capacity in congestive heart failure.Br J Clin Pharmacol1982https://conductscience.org/library/papers/6753895PubMed
6349967Vasodilator therapy in chronic congestive heart failure.Drugs1983https://conductscience.org/library/papers/6349967PubMed
6349763Vasodilators.Can Med Assoc J1983https://conductscience.org/library/papers/6349763PubMed
6125370Selection of vasodilator drugs for patients with severe chronic heart failure: an approach based on a new classification.Drugs1982https://conductscience.org/library/papers/6125370PubMed
6112039Treatment of chronic heart failure with pirbuterol: acute haemodynamic responses.Br Med J (Clin Res Ed)1981https://conductscience.org/library/papers/6112039PubMed
3758138The search of an ideal oral positive inotropic agent.Eur J Clin Pharmacol1986https://conductscience.org/library/papers/3758138PubMed
3304372Felodipine in patients with chronic heart failure: discrepant haemodynamic and clinical effects.Br Heart J1987https://conductscience.org/library/papers/3304372PubMed

See all 30 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/848799

GET https://conductscience.org/api/papers/v1/848799/cited_by?page=2